Eyal Epstein

848 total citations
27 papers, 356 citations indexed

About

Eyal Epstein is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Eyal Epstein has authored 27 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Infectious Diseases. Recurrent topics in Eyal Epstein's work include Toxin Mechanisms and Immunotoxins (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Transgenic Plants and Applications (5 papers). Eyal Epstein is often cited by papers focused on Toxin Mechanisms and Immunotoxins (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Transgenic Plants and Applications (5 papers). Eyal Epstein collaborates with scholars based in Israel and United States. Eyal Epstein's co-authors include Ohad Mazor, Ron Alcalay, Tal Noy-Porat, Ronit Rosenfeld, Chanoch Kronman, Adva Mechaly, Rachel Kilav, Tally Naveh‐Many, Eli Kedar and Justin Silver and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Eyal Epstein

26 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eyal Epstein Israel 13 143 121 69 62 50 27 356
Akiko Okayama Japan 13 228 1.6× 64 0.5× 13 0.2× 45 0.7× 22 0.4× 30 423
Namrata Tomar India 12 306 2.1× 101 0.8× 15 0.2× 52 0.8× 22 0.4× 23 454
Yiquan Li China 11 157 1.1× 43 0.4× 19 0.3× 113 1.8× 56 1.1× 43 359
Mohammed G. Ghonime United States 12 246 1.7× 164 1.4× 26 0.4× 40 0.6× 153 3.1× 16 492
Zhenhu Zhao China 12 190 1.3× 92 0.8× 28 0.4× 279 4.5× 65 1.3× 22 554
Kazuya Mori Japan 10 114 0.8× 60 0.5× 22 0.3× 30 0.5× 36 0.7× 21 329
L A Gyure United Kingdom 11 119 0.8× 157 1.3× 22 0.3× 75 1.2× 35 0.7× 20 477
Carolina Vizcaíno Colombia 11 405 2.8× 68 0.6× 8 0.1× 71 1.1× 34 0.7× 17 577
H. Bazin France 10 178 1.2× 78 0.6× 8 0.1× 15 0.2× 35 0.7× 28 391
Wenfang Tang Taiwan 8 158 1.1× 46 0.4× 11 0.2× 110 1.8× 16 0.3× 13 354

Countries citing papers authored by Eyal Epstein

Since Specialization
Citations

This map shows the geographic impact of Eyal Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eyal Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eyal Epstein more than expected).

Fields of papers citing papers by Eyal Epstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eyal Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eyal Epstein. The network helps show where Eyal Epstein may publish in the future.

Co-authorship network of co-authors of Eyal Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of Eyal Epstein. A scholar is included among the top collaborators of Eyal Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eyal Epstein. Eyal Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cherry, Lilach, Edith Lupu, Niva Natan, et al.. (2024). Development and Validation of a Plaque Assay to Determine the Titer of a Recombinant Live-Attenuated Viral Vaccine for SARS-CoV-2. Vaccines. 12(4). 374–374. 1 indexed citations
2.
Tamir, Hadas, Tal Noy-Porat, Sharon Melamed, et al.. (2024). Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infection. Nature Communications. 15(1). 3265–3265. 10 indexed citations
3.
Mechaly, Adva, Ron Alcalay, Eyal Epstein, et al.. (2022). Highly Specific Monoclonal Antibody Targeting the Botulinum Neurotoxin Type E Exposed SNAP-25 Neoepitope. Antibodies. 11(1). 21–21. 5 indexed citations
4.
Rosenfeld, Ronit, Ron Alcalay, Anat Zvi, et al.. (2022). Centaur antibodies: Engineered chimeric equine-human recombinant antibodies. Frontiers in Immunology. 13. 942317–942317. 4 indexed citations
5.
Mechaly, Adva, Uri Elia, Ron Alcalay, et al.. (2019). Inhibition of Francisella tularensis phagocytosis using a novel anti-LPS scFv antibody fragment. Scientific Reports. 9(1). 11418–11418. 13 indexed citations
6.
Mechaly, Adva, Ron Alcalay, Tal Noy-Porat, et al.. (2018). Novel Phage Display-Derived Anti-Abrin Antibodies Confer Post-Exposure Protection against Abrin Intoxication. Toxins. 10(2). 80–80. 12 indexed citations
7.
8.
Rosenfeld, Ronit, Ron Alcalay, Adva Mechaly, et al.. (2017). Improved antibody-based ricin neutralization by affinity maturation is correlated with slower off-rate values. Protein Engineering Design and Selection. 30(9). 611–617. 17 indexed citations
9.
Noy-Porat, Tal, Ron Alcalay, Eyal Epstein, et al.. (2017). Extended therapeutic window for post-exposure treatment of ricin intoxication conferred by the use of high-affinity antibodies. Toxicon. 127. 100–105. 17 indexed citations
10.
Epstein, Eyal, et al.. (2017). An in vitro cell-based potency assay for pharmaceutical type A botulinum antitoxins. Vaccine. 35(52). 7213–7216. 7 indexed citations
11.
Noy-Porat, Tal, Ronit Rosenfeld, Naomi Ariel, et al.. (2016). Isolation of Anti-Ricin Protective Antibodies Exhibiting High Affinity from Immunized Non-Human Primates. Toxins. 8(3). 64–64. 35 indexed citations
12.
Gal, Yoav, Ron Alcalay, Tamar Sabo, et al.. (2015). Rapid assessment of antibody-induced ricin neutralization by employing a novel functional cell-based assay. Journal of Immunological Methods. 424. 136–139. 11 indexed citations
13.
Mechaly, Adva, Haim Levy, Eyal Epstein, et al.. (2012). A Novel Mechanism for Antibody-based Anthrax Toxin Neutralization. Journal of Biological Chemistry. 287(39). 32665–32673. 21 indexed citations
14.
Lazar, Arye, et al.. (2002). Inactivation of West-Nile Virus During Peptic Cleavage of Horse Plasma IgG. Biologicals. 30(2). 163–165. 11 indexed citations
15.
Epstein, Eyal, Alin Sela-Brown, Israel Ringel, et al.. (2000). Dynein light chain binding to a 3′-untranslated sequence mediates parathyroid hormone mRNA association with microtubules. Journal of Clinical Investigation. 105(4). 505–512. 29 indexed citations
16.
Silver, J., et al.. (1996). New insights into the regulation of parathyroid hormone synthesis and secretion in chronic renal failure. Nephrology Dialysis Transplantation. 11(supp3). 2–5. 14 indexed citations
17.
Naveh‐Many, Tally, Eyal Epstein, & Justin Silver. (1995). Oestrogens and calcium regulatory hormones. Current Opinion in Nephrology & Hypertension. 4(4). 319–323. 4 indexed citations
18.
Silver, Justin, et al.. (1994). New aspects in the control of parathyroid hormone secretion. Current Opinion in Nephrology & Hypertension. 3(4). 379–385. 16 indexed citations
19.
Kedar, Eli, et al.. (1989). Chemo-immunotherapy of murine tumors using interleukin-2 (IL-2) and cyclophosphamide. Cancer Immunology Immunotherapy. 29(1). 74–8. 31 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akiko Okayama Breakdown of academic impact, for papers by Namrata Tomar Breakdown of academic impact, for papers by Yiquan Li Breakdown of academic impact, for papers by Mohammed G. Ghonime Breakdown of academic impact, for papers by Zhenhu Zhao Breakdown of academic impact, for papers by Kazuya Mori Breakdown of academic impact, for papers by L A Gyure Breakdown of academic impact, for papers by Carolina Vizcaíno Breakdown of academic impact, for papers by H. Bazin Breakdown of academic impact, for papers by Wenfang Tang
Rankless by CCL
2026